Biomedicines

Aims & Scope

Biomedicines (ISSN 2227-9059) is an open access journal devoted to research of naturally driven biomedicines, pharmaceuticals, and biopharmaceutical products.

The topics include natural bioactive molecules, biologics, biosimilar, vaccines, gene therapies, cell-based therapies, targeted specific antibodies, recombinant therapeutic proteins, nanobiotechnology driven products, targeted therapy, bioimaging, biosensors, biomarkers, nano-similars, and nano-biosimilars.

The journal is open for publication of studies conducted at the basic science, clinical development and clinical trial stages.

Also, publications that address safety, pharmacovigilance regulatory, and ethical issues are welcome.

We invite you to consider submitting your work to Biomedicines, be it original research, review articles, or developing special issues of current key topics.

The aim of Biomedicines is publishing high quality papers that address the challenges in bringing biological agents or novel targeted strategies through identification, developmentand ultimately to clinical use.

Therefore, basic research, comprehensive preclinical studies, clinical development, and clinical trials are all within the scope of the journal.

Natural Biomedicines Including Marine, Plant, and Animal-Derived Biomedicines; Biopharmaceutical Biomedicines: Biologics, and Biosimilar; Nanobiotechnological Advances in Biomedicines: Nanomedicine, Nanoscaffold Implants (Synthetic Vascular Graft), Biosensors, Bio imaging, Gene Therapy, Vaccine, Cell Therapy, and Tissue Engineering; Biomedicines and Pharmacotherapy: Drug Discovery and Drug Development (Novel Targets) in Various Therapeutic Areas: Cardiovascular, Vascular, Hematology, Oncology, Neurology, Orthopedics, Dermatology, Ophthalmology; Pharmacovigilance, Regulatory and Ethical Issues.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Biochemistry, Genetics and Molecular Biology and Medicine, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,600.00 CHF. Learn more.

Explore journals without APCs for alternative publishing options.